These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15003084)

  • 21. Diphenhydramine use in the treatment of risperidone-induced sialorrhea.
    Usta MG; Tufan AE; Cüceloğlu EA
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):254-5. PubMed ID: 22537186
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperprolactinemia with low dose of risperidone in a young female.
    Boothby A; Shad MU
    Asian J Psychiatr; 2017 Jun; 27():69-70. PubMed ID: 28558899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone treatment of an adolescent with severe posttraumatic stress disorder.
    Keeshin BR; Strawn JR
    Ann Pharmacother; 2009 Jul; 43(7):1374. PubMed ID: 19584378
    [No Abstract]   [Full Text] [Related]  

  • 25. Risperidone questioned as dementia first-line treatment.
    Saxe T
    Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
    [No Abstract]   [Full Text] [Related]  

  • 26. [Not Available].
    Muheim L
    Praxis (Bern 1994); 2017; 106(6):328-329. PubMed ID: 28299999
    [No Abstract]   [Full Text] [Related]  

  • 27. Bradycardia at low doses of risperidone.
    Tran KT; Golden P; Lark T; Jacob NJ
    Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.
    Suzuki Y; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):643-4. PubMed ID: 21044656
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone-induced priapism.
    Makesar D; Thome J
    World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone, tardive dyskinesia, and the elderly.
    Chaplin RH
    Am J Psychiatry; 2001 Aug; 158(8):1336-7. PubMed ID: 11481187
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 33. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 34. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone and tardive dyskinesia.
    Feeney DJ; Klykylo W
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
    [No Abstract]   [Full Text] [Related]  

  • 36. Edema associated with addition of risperidone to valproate treatment.
    Sanders RD; Lehrer DS
    J Clin Psychiatry; 1998 Dec; 59(12):689-90. PubMed ID: 9921707
    [No Abstract]   [Full Text] [Related]  

  • 37. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA; Kuiper J; Verwey B
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract]   [Full Text] [Related]  

  • 40. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.